Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing.

Contingent non-invasive prenatal testing models using more sensitive combined first trimester screening risk cut-offs than conventional screening improved the detection rate of trisomy 21, reduced procedure-related fetal loss and could potentially be provided at a lower cost per diagnosis than conventional screening.